Genomes.io
Healthcare Software · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
30 Caledonian Road, London, Greater Lond...Website
www.genomes.ioRevenue
<$5 MillionIndustry
About Genomes.io
Is Genomes.io your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Genomes.io is spiking on competitors!
Check if Genomes.io has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Genomes.io recently announced quarterly report
Click to see if Genomes.io had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genomes.io has new funding data
Congratulate Masked Content for being promoted to Masked Content at Genomes.io
Genomes.io, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Genomes.io launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Genomes.io
Compare insights from companies similar to Genomes.io, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Genomes.io
Company Profile Activity
Activity Insights
Genomes.io is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Genomes.io is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Genomes.io.
Genomes.io Tech Stack
A closer look at the technologies used by Genomes.io
Genomes.io News & Media
Genomes.io Secures $20M Commitment From GEM Digital
Genomes.io, a London, UK-based biotech company focused on the safe, private, and auditable monetization of genomic data, received a USD20m commitment from Bahamas-based digital asset investment firm GEM Digital Limited. The commitment will allow the company to accelerate its technological growth. Founded in London in 2018 by Aldo de Pape, CEO, Genomes.io is a secure DNA data […] The post Genomes.io Secures $20M Commitment From GEM Digital appeared first on FinSMEs.Genomes.io Secures a $20 Million Commitment From GEM Digital Limited
Genomes.io's $20 million financial commitment will assist the company in its mission to make the genomics market more equitable and transparent for all involved.The Future of Blockchain Technology in Synthetic Biology - OODA Loop
Synthetic biology is a field that involves the engineering of biological systems to create new organisms or modify existing ones for various applications, such as healthcare, agriculture, and industrial processes. We continue our efforts to understand the risks and opportunities in this exponential industry sector by taking a look at the role blockchain technology will play in synthetic biology, particularly in areas related to data management, security, and collaboration. This research is alsoGenomes.io Wins the Deloitte Tech Fast 50 Challenge Award
Genomes.io is very happy to announce it won the Deloitte Fast Tech 50 Challenge Award as the most innovative and impactful solution in its health ...
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genomes.io
DNA is the blueprint to what makes you who you are. It is the most valuable piece of personal information an individual will ever own. It is an appreciating asset that will continue to increase in value as genetic research continues to unlock mysteries in DNA over time. However, as soon as individuals send their saliva to a sequencing facility and... Read More